Back to Search Start Over

Metabolic recycling of storage lipids promotes squalene biosynthesis in yeast.

Authors :
Son SH
Kim JE
Moon SY
Jang IS
Yu BJ
Lee JY
Source :
Biotechnology for biofuels and bioproducts [Biotechnol Biofuels Bioprod] 2022 Oct 12; Vol. 15 (1), pp. 108. Date of Electronic Publication: 2022 Oct 12.
Publication Year :
2022

Abstract

Background: Metabolic rewiring in microbes is an economical and sustainable strategy for synthesizing valuable natural terpenes. Terpenes are the largest class of nature-derived specialized metabolites, and many have valuable pharmaceutical or biological activity. Squalene, a medicinal terpene, is used as a vaccine adjuvant to improve the efficacy of vaccines, including pandemic coronavirus disease 2019 (COVID-19) vaccines, and plays diverse biological roles as an antioxidant and anticancer agent. However, metabolic rewiring interferes with inherent metabolic pathways, often in a way that impairs the cellular growth and fitness of the microbial host. In particular, as the key starting molecule for producing various compounds including squalene, acetyl-CoA is involved in numerous biological processes with tight regulation to maintain metabolic homeostasis, which limits redirection of metabolic fluxes toward desired products.<br />Results: In this study, focusing on the recycling of surplus metabolic energy stored in lipid droplets, we show that the metabolic recycling of the surplus energy to acetyl-CoA can increase squalene production in yeast, concomitant with minimizing the metabolic interferences in inherent pathways. Moreover, by integrating multiple copies of the rate-limiting enzyme and implementing N-degron-dependent protein degradation to downregulate the competing pathway, we systematically rewired the metabolic flux toward squalene, enabling remarkable squalene production (1024.88 mg/L in a shake flask). Ultimately, further optimization of the fed-batch fermentation process enabled remarkable squalene production of 6.53 g/L.<br />Conclusions: Our demonstration of squalene production via engineered yeast suggests that plant- or animal-based supplies of medicinal squalene can potentially be complemented or replaced by industrial fermentation. This approach will also provide a universal strategy for the more stable and sustainable production of high-value terpenes.<br /> (© 2022. The Author(s).)

Details

Language :
English
ISSN :
2731-3654
Volume :
15
Issue :
1
Database :
MEDLINE
Journal :
Biotechnology for biofuels and bioproducts
Publication Type :
Academic Journal
Accession number :
36224649
Full Text :
https://doi.org/10.1186/s13068-022-02208-9